Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Licensing opportunity from NIH: novel antitumor macrocyclic lactones

July 9, 2001

Steroid sulfatase inhibitors in development by Novartis for cancer, etc.

July 6, 2001

Enzyme-inducing sulfenate and thiosulfinate esters described by U.S. university

July 6, 2001

WHI-P154 claimed for sensitizing cancer cells to radiation

July 6, 2001

Several series of antineoplastic agents presented by ADIR in patents

July 6, 2001

FDA grants approval for Debiopharm's Trelstar LA for use in advanced prostate cancer

July 6, 2001

Wyeth-Ayerst and Taxolog to develop novel taxanes

July 6, 2001

Peregrine's TNT treatment shows positive results in phase I/II trial

July 5, 2001

Bradykinin B2 antagonists with anticancer activity

July 5, 2001

AEterna's Neovastat demonstrates safety and dose-related activity in prostate cancer trial

July 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...